AlgoSensus

AI-based Balance Analysis Platform

Health Tech & Life Sciences
Active
Pre-Funding Herzliya, Israel Founded 2021
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2021
Headcount
3
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences

About

AlgoSensus combines artificial intelligence/machine learning, big data, and kinesics to reduce falls among the elderly. The company aims to make balance assessments and treatments empirical, consistent, objective, and scalable. AlgoSensus applies machine learning to data acquired via its Kinezio 4D balance-analysis platform. Based on individual and aggregated stability patterns, it provides personalized treatments via its mobile app and perturbation balance training devices. This ongoing, closed-loop program reduces falls, targeting neurological causes of imbalance. Combined with patient electronic medical records, its big dataset will also provide predictive diagnostics for neurodegenerative diseases. Partnerships with health information exchanges enable AlgoSensus to be insurance reimbursable as remote patient monitoring and software-as-medical-device. Driven by recurring mobile app subscriptions and Kinezio 4D sales (razor/blade), AlgoSensus also monetizes the big data it acquires from ongoing Kinezio 4D use.

Q&A

What is AlgoSensus's primary focus?
AlgoSensus focuses on reducing falls among the elderly by combining artificial intelligence/machine learning, big data, and kinesics for balance analysis and personalized treatments.
When was AlgoSensus founded?
AlgoSensus was founded in April 2021.
What is the current employee count at AlgoSensus?
AlgoSensus has 1-10 employees.
Where is AlgoSensus headquartered?
AlgoSensus is headquartered in Herzliya, Israel.
What is AlgoSensus's current funding stage?
AlgoSensus is currently in the Pre-Funding stage.
How does AlgoSensus generate revenue?
AlgoSensus generates revenue through recurring mobile app subscriptions, Kinezio 4D sales, and by monetizing the big data acquired from ongoing Kinezio 4D use.
What technologies does AlgoSensus utilize?
AlgoSensus utilizes Artificial Intelligence, Machine Learning, Platforms & Interfaces, Mobile, Communications, and IOT.
Who are the founders of AlgoSensus?
The founders of AlgoSensus include Yoram Ben Porat (Chairman), Yedidia Yossef (CEO), Shlomo Talitman (CFO), Josef Kaplan (CRO), and Steve Schuster (GM - North America).

Team · 5

Founder · Chairman
LinkedIn ↗
Founder · CEO
LinkedIn ↗
Founder · CFO
LinkedIn ↗
Founder · CRO
LinkedIn ↗
Founder · GM - North America
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient Remote Monitoring
Technologies
Artificial IntelligenceMachine LearningPlatforms & InterfacesMobileCommunicationsIOT
Target customers
Healthcare & Life SciencesHealthcareInsurance CompaniesProvidersPatientsConsumersDemographics & FamilySeniors
Business model
B2CB2B2CB2B

Highlights

Verified

Tags

fall-preventionmedical-technologiesdigital-healthcareclinicsdiagnosticsinsurance-companiesbig-datamobile-applicationsiotroboticsneurologybig-data-analyticsseniorshospitalsmedical-devicesmachine-learningartificial-intelligencedata-analyticspersonalizationhealthcare-providersremote-monitoring
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitealgosensus.com
LinkedInlinkedin.com/company/77677678

Identifiers & details

Founded2021-4
Employees (exact)3
OfficesNorthborough

Radar intelligence

Web history (Wayback)

Domainalgosensus.com

Certificate / subdomain footprint

Subdomains3